{"title": "Vaccines, Blood & Biologics", "author": "Center; Research", "url": "https://www.fda.gov/vaccines-blood-biologics", "hostname": "fda.gov", "description": "CBER protects and advances the public health by ensuring that biological products are safe and effective and available to those who need them.", "sitename": "FDA", "date": "2023-08-24", "cleaned_text": "Tests, Antigen Skin Test Blood, Blood Components, Blood Bank Devices, Blood Donor Screening Tests Gene-based Treatments, Cell-based Treatments, Cloning Guidance, Rules, SOPPS, Establishment Registration, Enforcement, Compliance Bone, Skin, Corneas, Ligaments, Tendons, Stem Cells, Sperm, Heart Valves Vaccines for Use in Children and Adults, Tuberculin Testing Transplantation of Non-Human Cells, Tissues or Organs Into a Human Advertising & Labeling, IND, Expanded Access, PMA, BLA, NDA, 510(k) Recalls, Shortages, Biological Product Deviation Reporting, Adverse Event Reporting, HIV Home Test Kits Regulatory Harmonization/ Convergence, WHO Engagements, Resources for Foreign Regulators Research by FDA Staff to Evaluate and Enhance the Safety of Biologic Products Information for Consumers, Health Professionals, Industry Latest news and event information from the Center for Biologics Evaluation and Research at FDA Information about Fecal Microbiota "}